Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases

BACKGROUND: Kras mutation has been associated with shorter overall survival and time to disease recurrence after resection of colorectal liver metastases (CLM). This study evaluated the prognostic value of Kras mutation in patients with CLM treated by percutaneous radiofrequency ablation (RFA). METH...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Shady, Waleed, Petre, Elena N., Vakiani, Efsevia, Ziv, Etay, Gonen, Mithat, Brown, Karen T., Kemeny, Nancy E., Solomon, Stephen B., Solit, David B., Sofocleous, Constantinos T.
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5630397/
https://ncbi.nlm.nih.gov/pubmed/29029497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19806
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares